PGxAI is an AI-powered pharmacogenetics platform that redefines precision medicine using proprietary algorithms and real-world data. Partnered with InterSystems, the largest patient data holder globally, and leveraging advanced tools like VectorSearch and GenAI, PGxAI accesses extensive real-world data to solve drug selection, dosage personalization, and identification of clinically relevant drug-drug interactions.
| Website | https://www.crunchbase.com/organization/pgxai |
| Revenue | $35.7 million |
| Employees | 9 (6 on RocketReach) |
| Founded | 2023 |
| Address | 330 E Charleston Rd, Palo Alto, California 94306, US |
| Phone | +1 415-246-5322 |
| Industry | Biotechnology Research |
| Keywords | Precision Medicine, Pharmacogenomics, Personalized Medicine, Ai-Powered Healthcare, Drug Response Prediction, Genomics, Artificial Intelligence, Patient Data Analytics, Healthcare Ai, Predictive Analytics, Clinical Decision Support, Genetic Testing, Healthcare Technology, Big Data Analytics, Machine Learning, Real World Data, Data Driven Healthcare, Drug Development |
Looking for a particular PGxAI employee's phone or email?
The PGxAI annual revenue was $35.7 million in 2026.
Mike Z. is the Co-Founder and Chief Executive Officer of PGxAI.
6 people are employed at PGxAI.
PGxAI is based in Palo Alto, California.